{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:00:29Z","timestamp":1790136029663,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,26]],"date-time":"2027-03-26T00:00:00Z","timestamp":1806019200000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma Management AG","doi-asserted-by":"publisher","award":["P0213104"],"award-info":[{"award-number":["P0213104"]}],"id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["RO1DK136011"],"award-info":[{"award-number":["RO1DK136011"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clim.2026.110699","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:55:16Z","timestamp":1773392116000},"page":"110699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot study"],"prefix":"10.1016","volume":"285","author":[{"given":"Divya","family":"Katikaneni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmay","family":"Arekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Al-Hraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Reedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Manolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Scindia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2026.110699_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-60761-800-3_13","article-title":"Systemic lupus erythematosus: from genes to organ damage","volume":"662","author":"Kyttaris","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clim.2026.110699_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar3251","article-title":"Abnormalities of T cell signaling in systemic lupus erythematosus","volume":"13","author":"Moulton","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2026.110699_bb0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fimmu.2014.00164","article-title":"Breaking immunological tolerance in systemic lupus erythematosus","volume":"5","author":"Pieterse","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0020","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2026.110699_bb0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol.\u202f: CJASN"},{"key":"10.1016\/j.clim.2026.110699_bb0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/BOR.0000000000000089","article-title":"The pathogenesis, diagnosis and treatment of lupus nephritis","volume":"26","author":"Schwartz","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2026.110699_bb0035","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2026.110699_bb0040","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2026.110699_bb0045","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0950-3536(05)80133-7","article-title":"Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators","volume":"7","author":"Hershko","year":"1994","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.clim.2026.110699_bb0050","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"Toxicity of iron and hydrogen peroxide: the Fenton reaction","volume":"82-83","author":"Winterbourn","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.clim.2026.110699_bb0055","article-title":"The potential role of Ferroptosis in systemic lupus erythematosus","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0060","doi-asserted-by":"crossref","first-page":"9353","DOI":"10.1038\/s41598-018-27107-8","article-title":"Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease","volume":"8","author":"van Raaij","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2026.110699_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","article-title":"Mechanisms controlling cellular and systemic iron homeostasis","volume":"25","author":"Galy","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.clim.2026.110699_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126493","article-title":"Hepcidin-Ferroportin interaction controls systemic Iron homeostasis","volume":"22","author":"Nemeth","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110699_bb0075","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI21441","article-title":"Anemia of inflammation: the cytokine-hepcidin link","volume":"113","author":"Andrews","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2026.110699_bb0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.2008.316","article-title":"Biomarkers of lupus nephritis determined by serial urine proteomics","volume":"74","author":"Zhang","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2026.110699_bb0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/0961203316659153","article-title":"The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares","volume":"26","author":"Indrakanti","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2026.110699_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","article-title":"Cellular Iron metabolism and regulation","volume":"1173","author":"Gao","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.clim.2026.110699_bb0095","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1038\/s41598-017-13029-4","article-title":"Renal iron accumulation occurs in lupus nephritis and iron chelation delays the onset of albuminuria","volume":"7","author":"Marks","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2026.110699_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110181","article-title":"Functional consequence of Iron dyshomeostasis and ferroptosis in systemic lupus erythematosus and lupus nephritis","volume":"262","author":"Morel","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2004.10.017","article-title":"Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species","volume":"119","author":"Pham","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.clim.2026.110699_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109213","article-title":"Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis","volume":"248","author":"Alli","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.kint.2020.01.025","article-title":"Modulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis","volume":"98","author":"Scindia","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2026.110699_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI129382","article-title":"Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of beta-thalassemia","volume":"130","author":"Manolova","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2026.110699_bb0125","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83053","article-title":"Structures of ferroportin in complex with its specific inhibitor vamifeport","volume":"12","author":"Lehmann","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.clim.2026.110699_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajh.25670","article-title":"Oral ferroportin inhibitor VIT-2763: first-in-human, phase 1 study in healthy volunteers","volume":"95","author":"Richard","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clim.2026.110699_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.HS9.0000843980.18213.bf","article-title":"S272: safety and preliminary PHARMACODYNAMIC effects of the FERROPORTIN inhibitor VAMIFEPORT (VIT-2763) in patients with non-transfusion-dependent BETA thalassemia (NTDT): results from a phase 2A study","volume":"6","author":"Taher","year":"2022","journal-title":"HemaSphere"},{"key":"10.1016\/j.clim.2026.110699_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103211","article-title":"Macrophages in lupus nephritis: exploring a potential new therapeutic avenue","volume":"21","author":"Kwant","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2026.110699_bb0145","doi-asserted-by":"crossref","first-page":"1477708","DOI":"10.3389\/fphar.2024.1477708","article-title":"Roles of macrophages in lupus nephritis","volume":"15","author":"Cheng","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2026.110699_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10534-019-00183-7","article-title":"Iron uptake by ZIP8 and ZIP14 in human proximal tubular epithelial cells","volume":"32","author":"van Raaij","year":"2019","journal-title":"Biometals"},{"key":"10.1016\/j.clim.2026.110699_bb0155","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2007-05-090019","article-title":"Autocrine formation of hepcidin induces iron retention in human monocytes","volume":"111","author":"Theurl","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2026.110699_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11255-013-0497-9","article-title":"Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin","volume":"46","author":"Eleftheriadis","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.clim.2026.110699_bb0165","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1523-1755.2001.00492.x","article-title":"Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages","volume":"59","author":"Hill","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2026.110699_bb0170","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.190.12.1813","article-title":"Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice","volume":"190","author":"Tesch","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110699_bb0175","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.3389\/fimmu.2019.03020","article-title":"Predominant role of immunoglobulin G in the pathogenesis of splenomegaly in murine lupus","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0180","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.4049\/jimmunol.1201621","article-title":"Absence of CD59 exacerbates systemic autoimmunity in MRL\/lpr mice","volume":"189","author":"Miwa","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102943","article-title":"Systematic review of anti-dsDNA testing for systemic lupus erythematosus: a meta-analysis of the diagnostic test specificity of an anti-dsDNA fluorescence enzyme immunoassay","volume":"20","author":"Orme","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2026.110699_bb0190","doi-asserted-by":"crossref","first-page":"F178","DOI":"10.1152\/ajprenal.00184.2023","article-title":"Renal-specific loss of ferroportin disrupts iron homeostasis and attenuates recovery from acute kidney injury","volume":"326","author":"Soofi","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.clim.2026.110699_bb0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1582-4934.2009.00985.x","article-title":"Ferroportin 1 is expressed basolaterally in rat kidney proximal tubule cells and iron excess increases its membrane trafficking","volume":"15","author":"Wolff","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clim.2026.110699_bb0200","doi-asserted-by":"crossref","first-page":"F107","DOI":"10.1152\/ajprenal.00037.2022","article-title":"Chemokine CCL2 from proximal tubular epithelial cells contributes to sepsis-induced acute kidney injury","volume":"323","author":"Jia","year":"2022","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.clim.2026.110699_bb0205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbrc.2019.11.066","article-title":"Local hepcidin increased intracellular iron overload via the degradation of ferroportin in the kidney","volume":"522","author":"Pan","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2026.110699_bb0210","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood-2012-07-440743","article-title":"Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis","volume":"120","author":"Ramos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2026.110699_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115649","article-title":"Essential role of hepcidin in host resistance to disseminated candidiasis","volume":"44","author":"Arekar","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2026.110699_bb0220","first-page":"43","article-title":"Therapeutic targeting of macrophages in lupus nephritis","volume":"20","author":"Chalmers","year":"2015","journal-title":"Discov. Med."},{"key":"10.1016\/j.clim.2026.110699_bb0225","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1128\/IAI.02863-14","article-title":"Increased ferroportin-1 expression and rapid splenic iron loss occur with anemia caused by salmonella enterica Serovar typhimurium infection in mice","volume":"83","author":"Brown","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2026.110699_bb0230","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210562","article-title":"Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2","volume":"219","author":"Mysore","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110699_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MNH.0000000000000186","article-title":"Monocyte chemoattractant protein-1 and the kidney","volume":"25","author":"Haller","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.clim.2026.110699_bb0240","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1172\/JCI67867","article-title":"Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury","volume":"123","author":"Zarjou","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2026.110699_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089355","article-title":"Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction","volume":"9","author":"Ikeda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2026.110699_bb0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/1753-0407.12420","article-title":"Effect of the oral iron chelator deferiprone in diabetic nephropathy rats","volume":"9","author":"Zou","year":"2017","journal-title":"J. Diabetes"},{"key":"10.1016\/j.clim.2026.110699_bb0255","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.2147\/JIR.S526096","article-title":"New targets for immune inflammatory response in rheumatoid arthritis: focus on the potential significance of N6-Methyladenosine, Ferroptosis and Cuproptosis","volume":"18","author":"Wang","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.clim.2026.110699_bb0260","doi-asserted-by":"crossref","first-page":"1610121","DOI":"10.3389\/fimmu.2025.1610121","article-title":"Targeting the ferroptosis pathway for rheumatoid arthritis: molecular mechanisms and prospects for inhibitor development","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0265","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1177\/09612033221102076","article-title":"Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis","volume":"31","author":"Wang","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2026.110699_bb0270","doi-asserted-by":"crossref","first-page":"110181","DOI":"10.1016\/j.clim.2024.110181","article-title":"Functional consequence of iron dyshomeostasis and ferroptosis in systemic lupus erythematosus and lupus nephritis","volume":"262","author":"Morel","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0275","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.2008050549","article-title":"The mesangial cell revisited: no cell is an island","volume":"20","author":"Schlondorff","year":"2009","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.clim.2026.110699_bb0280","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.addr.2010.08.011","article-title":"Mesangial pathology in glomerular disease: targets for therapeutic intervention","volume":"62","author":"Scindia","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.clim.2026.110699_bb0285","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1681\/ASN.2004110917","article-title":"Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis","volume":"16","author":"Yung","year":"2005","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.clim.2026.110699_bb0290","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0037-2016","article-title":"Macrophages and Iron metabolism","volume":"4","author":"Ganz","year":"2016","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.clim.2026.110699_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/jox15020052","article-title":"A novel protocol for culturing polarized proximal tubular epithelial cells from kidney biopsies: enhancing platforms for drug excretion and nephrotoxicity studies","volume":"15","author":"Petreski","year":"2025","journal-title":"J Xenobiot"},{"key":"10.1016\/j.clim.2026.110699_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.681748","article-title":"Macrophage heterogeneity in kidney injury and fibrosis","volume":"12","author":"Wen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0305","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clim.2016.08.019","article-title":"CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus","volume":"185","author":"Chalmers","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0310","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110699_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109765","article-title":"Transcriptomic and proteomic profiling reveals distinct pathogenic features of peripheral non-classical monocytes in systemic lupus erythematosus","volume":"255","author":"Stergioti","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0320","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000335733","article-title":"Regulation of macrophage and dendritic cell responses by their lineage precursors","volume":"4","author":"Cortez-Retamozo","year":"2012","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.clim.2026.110699_bb0325","doi-asserted-by":"crossref","first-page":"2319203","DOI":"10.1080\/08916934.2024.2319203","article-title":"Animal models of lupus nephritis: the past, present and a future outlook","volume":"57","author":"Katikaneni","year":"2024","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2026.110699_bb0330","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41590-021-00993-3","article-title":"Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity","volume":"22","author":"Li","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0335","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1681\/ASN.2015040461","article-title":"Renal handling of circulating and renal-synthesized Hepcidin and its protective effects against hemoglobin-mediated kidney injury","volume":"27","author":"van Swelm","year":"2016","journal-title":"J. Am. Soc. Nephrol.\u202f: JASN"},{"key":"10.1016\/j.clim.2026.110699_bb0340","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1182\/blood-2017-05-786590","article-title":"Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin","volume":"131","author":"Aschemeyer","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clim.2026.110699_bb0345","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2018-01-824151","article-title":"How does hepcidin hinder ferroportin activity?","volume":"131","author":"Zhang","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clim.2026.110699_bb0350","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1073\/pnas.0409409102","article-title":"Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin","volume":"102","author":"Knutson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2026.110699_bb0355","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.it.2011.03.007","article-title":"Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype","volume":"32","author":"Cairo","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2026.110699_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111585","article-title":"Macrophages and Iron: a special relationship","volume":"9","author":"Recalcati","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.clim.2026.110699_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105698","article-title":"Macrophage ferroportin serves as a therapeutic target against bacteria-induced acute lung injury by promoting barrier restoration","volume":"25","author":"Wang","year":"2022","journal-title":"iScience"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:37:04Z","timestamp":1779190624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"alternative-id":["S1521661626000379"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110699","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110699"}}